The Baltimore Ravens didn't make any more trades before the trade deadline, but they made a quiet addition to their active roster.

Novo Nordisk cuts sales and profits guidance amid obesity drug competition - The boss of the Wegovy firm linked its reduced guidance to the market for weight-loss treatments being ‘more competitive than ever’.

(RNS) — The Archdiocese of Washington said McElroy has a nonaggressive cancer that rarely causes pain and his prognosis is good.

While we’re still picking up the pieces from an action-packed slate last weekend, there’s a lot to look forward to